ShotBlocker® Injection Relief
Effective distraction from needle poke apprehension and anxiety.
Effective distraction from needle poke apprehension and anxiety.
A simple, non-invasive device that distracts patients from needle poke pain signals.
Design based on the Gate Control Theory of Pain, ShotBlocker creates a more positive experience for caregiver and patient by reducing shot anxiety.
A drug-free, cost-effective solution that instantly reduces needle pain by using blunt contact points to distract from pain signals.
Easy to use and versatile, it's ideal for both home and clinical use. ShotBlocker® is child-friendly, offering a faster and more affordable alternative to anesthetic creams or sprays.
It is proudly made in the U.S.A.
SKU: 8050
Package: 50 / Box
SKU: 8100
Package: 100 / Box
SKU: 8004
Package: 1000 / Box
ShotBlocker is designed to distract and comfort patients receiving intra-muscular or subcutaneous injections and needle pokes.
There are no absolute contraindications for use of the ShotBlocker.
Professional Use Only
You can order by contacting Bionix directly (bionix@bionix.com or 800.551.7096); contacting your distributor of choice or purchasing on Amazon (5 Count; 50 Count; 100 Count).
Shotblocker’s ability to block pain is based on the Gate Control Theory of Pain Management. The theory states that there is a gating mechanism in the spinal cord that can be either opened or closed. When opened, pain signals are transferred through small nerve fibers to the brain and a pain sensation is experienced. It has been found that the gate can be closed by simultaneous stimulation of large diameter nerve fibers, those that respond to touch.
Bionix Medical Technologies partnered with Flower Hospital in Toledo, Ohio to complete a study on the effectiveness of the ShotBlocker device. The results of the study show that the ShotBlocker significantly reduced pain from minor injections. View the ShotBlocker studies.
ShotBlocker is designed to be a single-patient use device to prevent cross contamination during injection procedures. The single-patient use feature of the ShotBlocker also eliminates the cost associated with resterilization.
At about .50 per device, the cost of ShotBlocker will be minimal compared to other methods that are currently used.
Sales Executive, Primary and Acute Care
Strategic Account Manager, Primary and Acute Care
National Account Manager, Government
Account Manager, International
Account Manager, International
National Account Manager, Distribution
Customer Relations Specialist, Primary and Acute Care
Suture removal is a critical step in the healing process after surgical procedures or wound closure.
Read MoreIn a hospital setting, electrical outlets are essential for powering the critical devices and equipment that support patient care.
Read More